My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 115

    1.

    Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells.

    Monti P, Scirpoli M, Maffi P, Piemonti L, Secchi A, Bonifacio E, Roncarolo MG, Battaglia M.

    Diabetes. 2008 Sep;57(9):2341-7. Epub 2008 Jun 16.PMID: 18559659 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.

    Singh AK, Horvath KA, Mohiuddin MM.

    Transplant Proc. 2009 Jan-Feb;41(1):418-21.PMID: 19249569 [PubMed - indexed for MEDLINE]Related articles

    3.

    Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin.

    Strauss L, Whiteside TL, Knights A, Bergmann C, Knuth A, Zippelius A.

    J Immunol. 2007 Jan 1;178(1):320-9.PMID: 17182569 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients.

    Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, Roncarolo MG.

    J Immunol. 2006 Dec 15;177(12):8338-47.PMID: 17142730 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.

    Qu Y, Zhang B, Zhao L, Liu G, Ma H, Rao E, Zeng C, Zhao Y.

    Transpl Immunol. 2007 Apr;17(3):153-61. Epub 2007 Jan 24.PMID: 17331841 [PubMed - indexed for MEDLINE]Related articles

    6.

    Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.

    Giorgini A, Noble A.

    J Leukoc Biol. 2007 Nov;82(5):1053-61. Epub 2007 Aug 7.PMID: 17684039 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.

    Keever-Taylor CA, Browning MB, Johnson BD, Truitt RL, Bredeson CN, Behn B, Tsao A.

    Cytotherapy. 2007;9(2):144-57.PMID: 17453966 [PubMed - indexed for MEDLINE]Related articles

    8.

    Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

    Battaglia M, Stabilini A, Roncarolo MG.

    Blood. 2005 Jun 15;105(12):4743-8. Epub 2005 Mar 3.PMID: 15746082 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cells.

    Xia G, Shah M, Luo X.

    Transl Res. 2009 Feb;153(2):60-70. Epub 2008 Dec 25. Review.PMID: 19138650 [PubMed - indexed for MEDLINE]Related articles

    10.

    Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells.

    Battaglia M, Stabilini A, Draghici E, Migliavacca B, Gregori S, Bonifacio E, Roncarolo MG.

    Diabetes. 2006 Jun;55(6):1571-80.PMID: 16731819 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    [Effect of Rapamycin on CD4(+) CD25(+) regulatory T cells in allo-transplantation tolerance model]

    Zheng YX, Hou GH, Song J, Zhang C, Liang T.

    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Apr;23(4):327-30. Chinese. PMID: 17428387 [PubMed - indexed for MEDLINE]Related articles

    12.

    The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.

    Sewgobind VD, Kho MM, van der Laan LJ, Hendrikx TK, van Dam T, Tilanus HW, IJzermans JN, Weimar W, Baan CC.

    Nephrol Dial Transplant. 2009 May;24(5):1635-44. Epub 2009 Jan 28.PMID: 19176684 [PubMed - indexed for MEDLINE]Related articles

    13.

    Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

    Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG, Levings MK.

    Int Immunol. 2007 Apr;19(4):345-54. Epub 2007 Feb 27.PMID: 17329235 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Clinical-grade preparation of human natural regulatory T-cells encoding the thymidine kinase suicide gene as a safety gene.

    Guillot-Delost M, Cheraï M, Hamel Y, Rosenzwajg M, Baillou C, Simonin G, Leclercq V, Mariotti-Ferrandiz ME, Six A, Bon-Durand V, Maury S, Salomon BL, Cohen JL, Klatzmann D, Lemoine FM.

    J Gene Med. 2008 Aug;10(8):834-46.PMID: 18615770 [PubMed - indexed for MEDLINE]Related articles

    15.

    Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.

    Venigalla RK, Tretter T, Krienke S, Max R, Eckstein V, Blank N, Fiehn C, Ho AD, Lorenz HM.

    Arthritis Rheum. 2008 Jul;58(7):2120-30.PMID: 18576316 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation.

    Korczak-Kowalska G, Wierzbicki P, Bocian K, Klosowska D, Niemczyk M, Wyzgal J, Korecka A, Durlik M, Chmura A, Paczek L, Górski A.

    Transplant Proc. 2007 Nov;39(9):2721-3.PMID: 18021968 [PubMed - indexed for MEDLINE]Related articles

    17.

    Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody can prevent rat cardiac allograft rejection.

    Kitazawa Y, Fujino M, Sakai T, Azuma H, Kimura H, Isaka Y, Takahara S, Hünig T, Abe R, Li XK.

    J Heart Lung Transplant. 2008 Apr;27(4):362-71.PMID: 18374871 [PubMed - indexed for MEDLINE]Related articles

    18.

    Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.

    Abdulahad WH, Stegeman CA, van der Geld YM, Doornbos-van der Meer B, Limburg PC, Kallenberg CG.

    Arthritis Rheum. 2007 Jun;56(6):2080-91.PMID: 17530650 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Expansion of human regulatory T-cells from patients with type 1 diabetes.

    Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, Ghosh T, Atkinson MA, Bluestone JA.

    Diabetes. 2009 Mar;58(3):652-62. Epub 2008 Dec 15.PMID: 19074986 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.

    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.

    Transplantation. 2009 Jan 27;87(2):198-206.PMID: 19155973 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity